Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor-Reference-Cited by-同舟云学术

Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor

Published:2005-08-18 Issue:19 Volume:48 Page:5900-5908
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Roehrig Susanne¹,Straub Alexander¹,Pohlmann Jens¹,Lampe Thomas¹,Pernerstorfer Josef¹,Schlemmer Karl-Heinz¹,Reinemer Peter¹,Perzborn Elisabeth¹

Affiliation:

1. Bayer HealthCare AG, D-42096 Wuppertal, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm050101d

Reference26 articles.

1. Managing Oral Anticoagulant Therapy

Cited by 412 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ErpY-like Protein Interaction with Host Thrombin and Fibrinogen Intervenes the Plasma Coagulation through Extrinsic and Intrinsic Pathways;ACS Infectious Diseases;2024-09-04

2. The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective;European Journal of Medicinal Chemistry;2024-09

3. Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors;Journal of Thrombosis and Haemostasis;2024-08

4. Accelerating Factor Xa inhibitor discovery with a de novo drug design pipeline;Chinese Journal of Chemical Engineering;2024-08

5. Rapidly Diverse Synthesis of N‐Aryl‐5‐Substituted‐2‐Oxazolidinones via Nucleophilic Epoxide Ring Opening and Intramolecular Acyl Substitution of Epoxy Carbamates;Asian Journal of Organic Chemistry;2024-07-24